CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 232

Industry reads hand-picked by our editors

Jan 10, 2019

STAT
California governor moves to bolster negotiating power for lower drug prices
Minneapolis Star Tribune
Sanford Health joins generic drug company
RAPS
First Patient Treated Under Right to Try Law

Jan 09, 2019

CNN
FDA employees think shutdown could be deadly
The Hill
Democrats seek early victories on drug prices
Bloomberg
Drugmaker Won't Put Price in TV Ads, But Patients Can Look It Up

Jan 08, 2019

The Wall Street Journal
Biotech Proposes Paying for Pricey Drugs by Installment
STAT
SCOTUS seems unlikely to overhaul popular drug industry legal strategy
The New Yorker
Is Marijuana as Safe as We Think?

Jan 07, 2019

STAT
A year after 'the Michaels,' more women will take the JPM stage
Reuters
AstraZeneca picks Baselga to lead oncology R&D in growth plan
The Wall
Ironwood Pharmaceuticals Picks AstraZeneca Executive to Be Next CEO

Jan 04, 2019

Bloomberg
Drug-Price Fight Squeezes Pharma Between Wall Street and Trump
Xconomy
For CAR-T Cancer Fighters in the Real World, Two Roads Diverge
STAT
Will San Francisco's issues push people away from J.P. Morgan?

Jan 03, 2019

STAT
SCOTUS to examine strategy drug makers use to sidestep patient lawsuits
TheStreet
Bausch Health shares jump on analyst upgrade
TechCrunch
As market shifts, Atlas Venture closes a $250 million fund to support its breakaway biotech bets

Jan 02, 2019

STAT
The inside story of PhRMA's biggest lobbying loss in years
Bloomberg
Moderna Analysts Plan Reckoning After Valuation Declines
Financial Times
Pharma finds its feet in fight against climate change
The Boston Globe
For head of Massachusetts' biotech trade group, drug progress is personal

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Understanding Publication Impact and Engagement with Data and AI-Driven Solutions Webinar - on demand • Provided by Altmetric
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.